activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	837985	CHEMBL663656	Inhibitory affect against rabbit deoxycytidine kinase	B	Nc1ccn([C@H]2C=C[C@@H](CO)O2)c(=O)n1	Outside typical range	CHEMBL2115278	=	Ki	nM	1100000.0	CHEMBL2447	Homo sapiens	Ki	uM	1100.0
	837985	CHEMBL663656	Inhibitory affect against rabbit deoxycytidine kinase	B	Nc1ccn([C@H]2C=C[C@@H](CO)O2)c(=O)n1	Outside typical range	CHEMBL2115278	=	Ki	nM	1100000.0	CHEMBL2447	Homo sapiens	Ki	uM	1100.0
	837986	CHEMBL663658	Inhibitory affect against rabbit deoxycytidine kinase and represented as molt/4F kinase.	B	Nc1ccn([C@H]2C=C[C@@H](CO)O2)c(=O)n1	Outside typical range	CHEMBL2115278	=	Ki	nM	4600000.0	CHEMBL2447	Homo sapiens	Ki	uM	4600.0
	840343	CHEMBL663659	Inhibitory affect against rabbit deoxycytidine kinase for [2-14C]-dCyd	B	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1		CHEMBL66115	=	Km	nM	1100.0	CHEMBL2447	Homo sapiens	Km	uM	1.1
	840344	CHEMBL858733	Inhibitory affect against rabbit deoxycytidine kinase and represented as molt/4F kinase for [2-14C]-dCyd	B	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1		CHEMBL66115	=	Km	nM	2800.0	CHEMBL2447	Homo sapiens	Km	uM	2.8
	856626	CHEMBL663656	Inhibitory affect against rabbit deoxycytidine kinase	B	Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1	Outside typical range	CHEMBL853	=	Ki	nM	360000.0	CHEMBL2447	Homo sapiens	Ki	uM	360.0
	856627	CHEMBL663657	Inhibitory affect against rabbit deoxycytidine kinase and represented as molt/4F kinase in two references.	B	Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1	Outside typical range	CHEMBL853	=	Ki	nM	1000000.0	CHEMBL2447	Homo sapiens	Ki	uM	1000.0
	1075879	CHEMBL858732	Inhibitory activity against Cytidine Kinase	B	NC1=NC=NC2C1N=CN2C1CCC(CO)O1		CHEMBL128484	=	Km	nM	195000.0	CHEMBL2447	Homo sapiens	Km	uM	195.0
	1076989	CHEMBL858732	Inhibitory activity against Cytidine Kinase	B	Nc1ncnc2c1ncn2[C@H]1CC[C@@H](CO)O1		CHEMBL23094	=	Km	nM	220000.0	CHEMBL2447	Homo sapiens	Km	uM	220.0
	1086089	CHEMBL858732	Inhibitory activity against Cytidine Kinase	B	NC1=NC=NC2C1N=CN2C1C=CC(CO)O1		CHEMBL338540	=	Km	nM	4400000.0	CHEMBL2447	Homo sapiens	Km	uM	4400.0
	1089468	CHEMBL665310	Inhibitory activity against human deoxycytidine kinase	B	Nc1ncnc2c1ncn2[C@H]1C=C[C@@H](CO)O1		CHEMBL290427	=	Km	nM	620000.0	CHEMBL2447	Homo sapiens	Km	uM	620.0
Not Active	1772045	CHEMBL908313	Inhibition of human dCK activity	B	O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12		CHEMBL218291		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772046	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.Nc1nc(O)c2[nH]cc(CN3CCCC(CO)C3)c2n1		CHEMBL1161902		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772047	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.Nc1nc(O)c2[nH]cc(CNCCO)c2n1		CHEMBL1161901		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772048	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.Nc1nc(O)c2[nH]cc(CN(CCO)CCO)c2n1		CHEMBL1161900		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772049	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.CCN(CCO)Cc1c[nH]c2c(O)nc(N)nc12		CHEMBL1161899		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772050	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.CN(CCO)Cc1c[nH]c2c(O)nc(N)nc12		CHEMBL1161898		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772051	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.NC[C@@H]1CCCN1Cc1c[nH]c2c(O)nc(N)nc12		CHEMBL1161897		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772052	CHEMBL908313	Inhibition of human dCK activity	B	Nc1nc(O)c2[nH]cc(CN3C[C@H](O)C[C@H]3CO)c2n1		CHEMBL385263		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772053	CHEMBL908313	Inhibition of human dCK activity	B	COC[C@@H]1CCCN1Cc1c[nH]c2c(O)nc(N)nc12		CHEMBL216925		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772054	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.Nc1nc(O)c2[nH]cc(CN3CCC[C@@H]3CO)c2n1		CHEMBL1161896		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	1772055	CHEMBL908313	Inhibition of human dCK activity	B	CC(=O)O.Nc1nc(O)c2[nH]cc(CN3CCC[C@H]3CO)c2n1		CHEMBL1161895		Activity			CHEMBL2447	Homo sapiens	Activity		
	1835597	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1		CHEMBL66115	=	Km	nM	400.0	CHEMBL2447	Homo sapiens	Km	uM	0.4
	1835598	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888	=	Km	nM	1400.0	CHEMBL2447	Homo sapiens	Km	uM	1.4
	1835600	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2F)c(=O)n1		CHEMBL374528	=	Km	nM	4700.0	CHEMBL2447	Homo sapiens	Km	uM	4.7
	1835602	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	C[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL225276	=	Km	nM	46200.0	CHEMBL2447	Homo sapiens	Km	uM	46.2
	1835605	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL95606	=	Km	nM	6600.0	CHEMBL2447	Homo sapiens	Km	uM	6.6
	1835606	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL223482	=	Km	nM	81200.0	CHEMBL2447	Homo sapiens	Km	uM	81.2
	1835607	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL438605	=	Km	nM	914000.0	CHEMBL2447	Homo sapiens	Km	uM	914.0
	1835661	CHEMBL910984	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	B	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1		CHEMBL66115	=	Kcat/Km	/uM/s	0.063	CHEMBL2447	Homo sapiens	Kcat/Km	/uM/s	0.063
	1835663	CHEMBL910984	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888	=	Kcat/Km	/uM/s	0.027	CHEMBL2447	Homo sapiens	Kcat/Km	/uM/s	0.027
	1835664	CHEMBL910984	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2F)c(=O)n1		CHEMBL374528	=	Kcat/Km	/uM/s	0.011	CHEMBL2447	Homo sapiens	Kcat/Km	/uM/s	0.011
	1835668	CHEMBL910984	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL95606	=	Kcat/Km	/uM/s	0.0014	CHEMBL2447	Homo sapiens	Kcat/Km	/uM/s	0.0014
	1835669	CHEMBL910984	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL223482	=	Kcat/Km	/uM/s	0.00019	CHEMBL2447	Homo sapiens	Kcat/Km	/uM/s	0.00019
	1835672	CHEMBL910984	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	B	C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL438605	=	Kcat/Km	/uM/s	0.000012	CHEMBL2447	Homo sapiens	Kcat/Km	/uM/s	0.000012
	1835754	CHEMBL910984	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	B	C[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL225276	=	Kcat/Km	/uM/s	0.001	CHEMBL2447	Homo sapiens	Kcat/Km	/uM/s	0.001
	1836554	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1		CHEMBL66115	=	Kcat	/s	0.025	CHEMBL2447	Homo sapiens	Kcat	/s	0.025
	1836556	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888	=	Kcat	/s	0.038	CHEMBL2447	Homo sapiens	Kcat	/s	0.038
	1836558	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2F)c(=O)n1		CHEMBL374528	=	Kcat	/s	0.05	CHEMBL2447	Homo sapiens	Kcat	/s	0.05
	1836561	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	C[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL225276	=	Kcat	/s	0.048	CHEMBL2447	Homo sapiens	Kcat	/s	0.048
	1836562	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL95606	=	Kcat	/s	0.009	CHEMBL2447	Homo sapiens	Kcat	/s	0.009
	1836564	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL223482	=	Kcat	/s	0.016	CHEMBL2447	Homo sapiens	Kcat	/s	0.016
	1836591	CHEMBL910985	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	B	C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL438605	=	Kcat	/s	0.011	CHEMBL2447	Homo sapiens	Kcat	/s	0.011
	2450887	CHEMBL950384	Activity of human wild type deoxycytidine kinase in presence of ATP	B	Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL449329	=	Kcat	/s	2.1	CHEMBL2447	Homo sapiens	Kcat	/s	2.1
	2450888	CHEMBL950384	Activity of human wild type deoxycytidine kinase in presence of ATP	B	Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL449329	=	Km	nM	115000.0	CHEMBL2447	Homo sapiens	Km	uM	115.0
	2450889	CHEMBL950385	Activity of human wild type deoxycytidine kinase in presence of UTP	B	Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL449329	=	Kcat	/s	0.37	CHEMBL2447	Homo sapiens	Kcat	/s	0.37
	2450890	CHEMBL950385	Activity of human wild type deoxycytidine kinase in presence of UTP	B	Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL449329	=	Km	nM	8500.0	CHEMBL2447	Homo sapiens	Km	uM	8.5
	2450891	CHEMBL950386	Ratio of Kcat for human wild type deoxycytidine kinase to Km for human wild type deoxycytidine kinase in presence of ATP	B	Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL449329	=	Ratio	/s/microM	0.0182	CHEMBL2447	Homo sapiens	Ratio	/s/microM	0.0182
	2450892	CHEMBL950387	Ratio of Kcat for human wild type deoxycytidine kinase to Km for human wild type deoxycytidine kinase in presence of UTP	B	Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL449329	=	Ratio	/s/microM	0.0435	CHEMBL2447	Homo sapiens	Ratio	/s/microM	0.0435
	2450893	CHEMBL950384	Activity of human wild type deoxycytidine kinase in presence of ATP	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619	=	Kcat	/s	0.6	CHEMBL2447	Homo sapiens	Kcat	/s	0.6
	2450894	CHEMBL950384	Activity of human wild type deoxycytidine kinase in presence of ATP	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619	=	Km	nM	78000.0	CHEMBL2447	Homo sapiens	Km	uM	78.0
	2450895	CHEMBL950384	Activity of human wild type deoxycytidine kinase in presence of ATP	B	Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1		CHEMBL68908	=	Kcat	/s	2.5	CHEMBL2447	Homo sapiens	Kcat	/s	2.5
	2450896	CHEMBL950384	Activity of human wild type deoxycytidine kinase in presence of ATP	B	Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1		CHEMBL68908	=	Km	nM	181000.0	CHEMBL2447	Homo sapiens	Km	uM	181.0
	2450897	CHEMBL950385	Activity of human wild type deoxycytidine kinase in presence of UTP	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619	=	Kcat	/s	0.37	CHEMBL2447	Homo sapiens	Kcat	/s	0.37
	2450898	CHEMBL950385	Activity of human wild type deoxycytidine kinase in presence of UTP	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619	=	Km	nM	5100.0	CHEMBL2447	Homo sapiens	Km	uM	5.1
	2450899	CHEMBL950385	Activity of human wild type deoxycytidine kinase in presence of UTP	B	Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1		CHEMBL68908	=	Kcat	/s	0.53	CHEMBL2447	Homo sapiens	Kcat	/s	0.53
	2450900	CHEMBL950385	Activity of human wild type deoxycytidine kinase in presence of UTP	B	Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1		CHEMBL68908	=	Km	nM	41000.0	CHEMBL2447	Homo sapiens	Km	uM	41.0
	2450901	CHEMBL950386	Ratio of Kcat for human wild type deoxycytidine kinase to Km for human wild type deoxycytidine kinase in presence of ATP	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619	=	Ratio	/s/microM	0.0077	CHEMBL2447	Homo sapiens	Ratio	/s/microM	0.0077
	2450902	CHEMBL950386	Ratio of Kcat for human wild type deoxycytidine kinase to Km for human wild type deoxycytidine kinase in presence of ATP	B	Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1		CHEMBL68908	=	Ratio	/s/microM	0.0138	CHEMBL2447	Homo sapiens	Ratio	/s/microM	0.0138
	2450903	CHEMBL950387	Ratio of Kcat for human wild type deoxycytidine kinase to Km for human wild type deoxycytidine kinase in presence of UTP	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619	=	Ratio	/s/microM	0.0726	CHEMBL2447	Homo sapiens	Ratio	/s/microM	0.0726
	2450904	CHEMBL950387	Ratio of Kcat for human wild type deoxycytidine kinase to Km for human wild type deoxycytidine kinase in presence of UTP	B	Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1		CHEMBL68908	=	Ratio	/s/microM	0.0129	CHEMBL2447	Homo sapiens	Ratio	/s/microM	0.0129
	2711773	CHEMBL1064146	Ratio of Kcat to Km for cloned 2'-deoxycytidine kinase in human HepG2 cells assessed as formation of formation of PS-6130 monophosphate by spectrophotometry	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL223482	=	Kcat/Km	10'-4/uM/s	1.9	CHEMBL2447	Homo sapiens	Kcat/Km	10'-4/uM/s	1.9
Not Active	2711791	CHEMBL1064155	Activity of cloned deoxycytidine kinase in human HepG2 cells up to 1 mM	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O		CHEMBL510394		Activity			CHEMBL2447	Homo sapiens	Activity		
	3232883	CHEMBL1101183	Inhibition of human dCK	B	O=C(CN1CCN(c2cc(-c3cc4ccccc4s3)ncn2)CC1)N1CCCC1	Outside typical range	CHEMBL1081559	=	IC50	nM	510000.0	CHEMBL2447	Homo sapiens	IC50	uM	510.0
	3232884	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F	Outside typical range	CHEMBL1076257	=	IC50	nM	120000.0	CHEMBL2447	Homo sapiens	IC50	uM	120.0
	3232885	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(Oc2cc(-c3cc4ccccc4s3)ncn2)ncc1F		CHEMBL1081560	=	IC50	nM	720.0	CHEMBL2447	Homo sapiens	IC50	uM	0.72
	3232886	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OC2CCN(c3cc(-c4cc5ccccc5s4)ncn3)CC2)ncc1F		CHEMBL1081561	=	IC50	nM	38.0	CHEMBL2447	Homo sapiens	IC50	uM	0.038
	3232887	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OCC2CCN(c3cc(-c4cc5ccccc5s4)ncn3)CC2)ncc1F		CHEMBL1079585	=	IC50	nM	34.0	CHEMBL2447	Homo sapiens	IC50	uM	0.034
	3232888	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OCCC2CCN(c3cc(-c4cc5ccccc5s4)ncn3)CC2)ncc1F		CHEMBL1079768	=	IC50	nM	3.0	CHEMBL2447	Homo sapiens	IC50	uM	0.003
	3232889	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4)ncn3)CC2)ncc1F		CHEMBL1079769	=	IC50	nM	95.0	CHEMBL2447	Homo sapiens	IC50	uM	0.095
	3232890	CHEMBL1101183	Inhibition of human dCK	B	COc1ccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)cc1		CHEMBL1079770	=	IC50	nM	33.0	CHEMBL2447	Homo sapiens	IC50	uM	0.033
	3232891	CHEMBL1101183	Inhibition of human dCK	B	COc1cccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)c1		CHEMBL1076272	=	IC50	nM	23.0	CHEMBL2447	Homo sapiens	IC50	uM	0.023
	3232892	CHEMBL1101183	Inhibition of human dCK	B	COc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079601	=	IC50	nM	5.0	CHEMBL2447	Homo sapiens	IC50	uM	0.005
	3232893	CHEMBL1101183	Inhibition of human dCK	B	Cc1ccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)cc1		CHEMBL1079602	=	IC50	nM	21.0	CHEMBL2447	Homo sapiens	IC50	uM	0.021
	3232894	CHEMBL1101183	Inhibition of human dCK	B	Cc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079603	=	IC50	nM	9.0	CHEMBL2447	Homo sapiens	IC50	uM	0.009
	3232895	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4-c4ccccc4)ncn3)CC2)ncc1F		CHEMBL1081350	=	IC50	nM	3.0	CHEMBL2447	Homo sapiens	IC50	uM	0.003
	3232896	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OC2CCN(c3cc(Oc4ccc(Cl)cc4)ncn3)CC2)ncc1F		CHEMBL1081351	=	IC50	nM	19.0	CHEMBL2447	Homo sapiens	IC50	uM	0.019
	3232897	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OC2CCN(c3cc(Oc4cccc(Cl)c4)ncn3)CC2)ncc1F		CHEMBL1081352	=	IC50	nM	22.0	CHEMBL2447	Homo sapiens	IC50	uM	0.022
	3232898	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4Cl)ncn3)CC2)ncc1F		CHEMBL1080443	=	IC50	nM	3.0	CHEMBL2447	Homo sapiens	IC50	uM	0.003
	3232899	CHEMBL1101183	Inhibition of human dCK	B	CCc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079735	=	IC50	nM	10.0	CHEMBL2447	Homo sapiens	IC50	uM	0.01
	3232900	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079906	=	IC50	nM	3.0	CHEMBL2447	Homo sapiens	IC50	uM	0.003
	3232901	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1cccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)c1		CHEMBL1079907	=	IC50	nM	13.0	CHEMBL2447	Homo sapiens	IC50	uM	0.013
	3232902	CHEMBL1101183	Inhibition of human dCK	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4F)ncn3)CC2)ncc1F		CHEMBL1081901	=	IC50	nM	6.0	CHEMBL2447	Homo sapiens	IC50	uM	0.006
	3232903	CHEMBL1101183	Inhibition of human dCK	B	Cc1cc(Cl)ccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1081544	=	IC50	nM	9.0	CHEMBL2447	Homo sapiens	IC50	uM	0.009
	3232904	CHEMBL1101183	Inhibition of human dCK	B	COc1ccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)c(C#N)c1		CHEMBL1080636	=	IC50	nM	3.0	CHEMBL2447	Homo sapiens	IC50	uM	0.003
	3232905	CHEMBL1101183	Inhibition of human dCK	B	Cc1c(Oc2ccccc2C#N)ncnc1N1CCC(Oc2ncc(F)c(N)n2)CC1		CHEMBL1080817	=	IC50	nM	21.0	CHEMBL2447	Homo sapiens	IC50	uM	0.021
	3232906	CHEMBL1101183	Inhibition of human dCK	B	Cc1nc(Oc2ccccc2C#N)cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)n1		CHEMBL1080818	=	IC50	nM	10.0	CHEMBL2447	Homo sapiens	IC50	uM	0.01
	3232907	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1ccccc1Oc1ncnc(N2CCC(Oc3ncc(F)c(N)n3)CC2)c1Br		CHEMBL1080092	=	IC50	nM	5.0	CHEMBL2447	Homo sapiens	IC50	uM	0.005
	3232908	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1ccccc1Oc1ncnc(N2CCC(Oc3ncc(F)c(N)n3)CC2)c1F		CHEMBL1080093	=	IC50	nM	1.0	CHEMBL2447	Homo sapiens	IC50	uM	0.001
	3232909	CHEMBL1101183	Inhibition of human dCK	B	COc1ccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)cc1		CHEMBL1079379	=	IC50	nM	4.0	CHEMBL2447	Homo sapiens	IC50	uM	0.004
	3232910	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1cccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)c1		CHEMBL1079380	=	IC50	nM	4.0	CHEMBL2447	Homo sapiens	IC50	uM	0.004
	3232911	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1ccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)cc1		CHEMBL1081727	=	IC50	nM	5.0	CHEMBL2447	Homo sapiens	IC50	uM	0.005
	3232912	CHEMBL1101183	Inhibition of human dCK	B	COc1ccc(C#N)cc1Oc1ncnc(N2CCC(Oc3ncc(F)c(N)n3)CC2)c1F		CHEMBL1081903	=	IC50	nM	1.0	CHEMBL2447	Homo sapiens	IC50	uM	0.001
	3232913	CHEMBL1101183	Inhibition of human dCK	B	COc1ccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)c(C#N)c1		CHEMBL1081904	=	IC50	nM	2.0	CHEMBL2447	Homo sapiens	IC50	uM	0.002
	3232914	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1ccccc1Oc1ncnc(N2CCC(Oc3nccc(N)n3)CC2)c1F		CHEMBL1081002	=	IC50	nM	0.7	CHEMBL2447	Homo sapiens	IC50	uM	0.0007
	3232915	CHEMBL1101183	Inhibition of human dCK	B	N#Cc1ccccc1Oc1ncnc(N2CCC(On3ccc(N)nc3=O)CC2)c1F		CHEMBL1080829	=	IC50	nM	63.0	CHEMBL2447	Homo sapiens	IC50	uM	0.063
	3232916	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	O=C(CN1CCN(c2cc(-c3cc4ccccc4s3)ncn2)CC1)N1CCCC1		CHEMBL1081559	>	IC50	nM	4000.0	CHEMBL2447	Homo sapiens	IC50	uM	4.0
	3232917	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F		CHEMBL1076257	>	IC50	nM	4000.0	CHEMBL2447	Homo sapiens	IC50	uM	4.0
	3232918	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(Oc2cc(-c3cc4ccccc4s3)ncn2)ncc1F		CHEMBL1081560	=	EC50	nM	13000.0	CHEMBL2447	Homo sapiens	EC50	uM	13.0
	3232919	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OC2CCN(c3cc(-c4cc5ccccc5s4)ncn3)CC2)ncc1F		CHEMBL1081561	=	EC50	nM	700.0	CHEMBL2447	Homo sapiens	EC50	uM	0.7
	3232920	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OCC2CCN(c3cc(-c4cc5ccccc5s4)ncn3)CC2)ncc1F		CHEMBL1079585	=	EC50	nM	790.0	CHEMBL2447	Homo sapiens	EC50	uM	0.79
	3232921	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OCCC2CCN(c3cc(-c4cc5ccccc5s4)ncn3)CC2)ncc1F		CHEMBL1079768	=	EC50	nM	160.0	CHEMBL2447	Homo sapiens	EC50	uM	0.16
	3232922	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4)ncn3)CC2)ncc1F		CHEMBL1079769	=	EC50	nM	340.0	CHEMBL2447	Homo sapiens	EC50	uM	0.34
	3232923	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	COc1ccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)cc1		CHEMBL1079770	=	EC50	nM	890.0	CHEMBL2447	Homo sapiens	EC50	uM	0.89
	3232924	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	COc1cccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)c1		CHEMBL1076272	=	EC50	nM	36.0	CHEMBL2447	Homo sapiens	EC50	uM	0.036
	3232925	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	COc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079601	=	EC50	nM	17.0	CHEMBL2447	Homo sapiens	EC50	uM	0.017
	3232926	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Cc1ccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)cc1		CHEMBL1079602	=	EC50	nM	60.0	CHEMBL2447	Homo sapiens	EC50	uM	0.06
	3232927	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Cc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079603	=	EC50	nM	19.0	CHEMBL2447	Homo sapiens	EC50	uM	0.019
	3232928	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4-c4ccccc4)ncn3)CC2)ncc1F		CHEMBL1081350	=	EC50	nM	26.0	CHEMBL2447	Homo sapiens	EC50	uM	0.026
	3232929	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OC2CCN(c3cc(Oc4ccc(Cl)cc4)ncn3)CC2)ncc1F		CHEMBL1081351	=	EC50	nM	57.0	CHEMBL2447	Homo sapiens	EC50	uM	0.057
	3232930	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OC2CCN(c3cc(Oc4cccc(Cl)c4)ncn3)CC2)ncc1F		CHEMBL1081352	=	EC50	nM	35.0	CHEMBL2447	Homo sapiens	EC50	uM	0.035
	3232931	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4Cl)ncn3)CC2)ncc1F		CHEMBL1080443	=	EC50	nM	13.0	CHEMBL2447	Homo sapiens	EC50	uM	0.013
	3232932	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	CCc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079735	=	EC50	nM	61.0	CHEMBL2447	Homo sapiens	EC50	uM	0.061
	3232933	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1ccccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1079906	=	EC50	nM	14.0	CHEMBL2447	Homo sapiens	EC50	uM	0.014
	3232934	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1cccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)c1		CHEMBL1079907	=	EC50	nM	61.0	CHEMBL2447	Homo sapiens	EC50	uM	0.061
	3232935	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Nc1nc(OC2CCN(c3cc(Oc4ccccc4F)ncn3)CC2)ncc1F		CHEMBL1081901	=	EC50	nM	15.0	CHEMBL2447	Homo sapiens	EC50	uM	0.015
	3232936	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Cc1cc(Cl)ccc1Oc1cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)ncn1		CHEMBL1081544	=	EC50	nM	27.0	CHEMBL2447	Homo sapiens	EC50	uM	0.027
	3232937	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	COc1ccc(Oc2cc(N3CCC(Oc4ncc(F)c(N)n4)CC3)ncn2)c(C#N)c1		CHEMBL1080636	=	EC50	nM	12.0	CHEMBL2447	Homo sapiens	EC50	uM	0.012
	3232938	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Cc1c(Oc2ccccc2C#N)ncnc1N1CCC(Oc2ncc(F)c(N)n2)CC1		CHEMBL1080817	=	EC50	nM	54.0	CHEMBL2447	Homo sapiens	EC50	uM	0.054
	3232939	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	Cc1nc(Oc2ccccc2C#N)cc(N2CCC(Oc3ncc(F)c(N)n3)CC2)n1		CHEMBL1080818	=	EC50	nM	140.0	CHEMBL2447	Homo sapiens	EC50	uM	0.14
	3232940	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1ccccc1Oc1ncnc(N2CCC(Oc3ncc(F)c(N)n3)CC2)c1Br		CHEMBL1080092	=	EC50	nM	80.0	CHEMBL2447	Homo sapiens	EC50	uM	0.08
	3232941	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1ccccc1Oc1ncnc(N2CCC(Oc3ncc(F)c(N)n3)CC2)c1F		CHEMBL1080093	=	EC50	nM	4.0	CHEMBL2447	Homo sapiens	EC50	uM	0.004
	3232942	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	COc1ccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)cc1		CHEMBL1079379	=	EC50	nM	14.0	CHEMBL2447	Homo sapiens	EC50	uM	0.014
	3232943	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1cccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)c1		CHEMBL1079380	=	EC50	nM	13.0	CHEMBL2447	Homo sapiens	EC50	uM	0.013
	3232944	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1ccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)cc1		CHEMBL1081727	=	EC50	nM	20.0	CHEMBL2447	Homo sapiens	EC50	uM	0.02
	3232945	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	COc1ccc(C#N)cc1Oc1ncnc(N2CCC(Oc3ncc(F)c(N)n3)CC2)c1F		CHEMBL1081903	=	EC50	nM	2.0	CHEMBL2447	Homo sapiens	EC50	uM	0.002
	3232946	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	COc1ccc(Oc2ncnc(N3CCC(Oc4ncc(F)c(N)n4)CC3)c2F)c(C#N)c1		CHEMBL1081904	=	EC50	nM	5.0	CHEMBL2447	Homo sapiens	EC50	uM	0.005
	3232947	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1ccccc1Oc1ncnc(N2CCC(Oc3nccc(N)n3)CC2)c1F		CHEMBL1081002	=	EC50	nM	5.0	CHEMBL2447	Homo sapiens	EC50	uM	0.005
	3232948	CHEMBL1101184	Inhibition of dCK in human CCRF-CEM assessed as inhibition of Ara-C phosphorylation	B	N#Cc1ccccc1Oc1ncnc(N2CCC(On3ccc(N)nc3=O)CC2)c1F		CHEMBL1080829	=	EC50	nM	350.0	CHEMBL2447	Homo sapiens	EC50	uM	0.35
	3234224	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)C2)cc1F		CHEMBL1079347	=	IC50	nM	3200.0	CHEMBL2447	Homo sapiens	IC50	nM	3200.0
	3234225	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)C2)cc1F		CHEMBL1079348	=	IC50	nM	3600.0	CHEMBL2447	Homo sapiens	IC50	nM	3600.0
	3234226	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Br)cc3)C2)cc1F		CHEMBL1079349	=	IC50	nM	2700.0	CHEMBL2447	Homo sapiens	IC50	nM	2700.0
	3234227	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccc(-c4ccccc4)cc3)C2)cc1F		CHEMBL1081909	=	IC50	nM	350.0	CHEMBL2447	Homo sapiens	IC50	nM	350.0
	3234228	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Br)c3)C2)cc1F		CHEMBL1081005	=	IC50	nM	1900.0	CHEMBL2447	Homo sapiens	IC50	nM	1900.0
	3234229	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccccc4)c3)C2)cc1F		CHEMBL1081006	=	IC50	nM	120.0	CHEMBL2447	Homo sapiens	IC50	nM	120.0
	3234230	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Cc1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1081189	=	IC50	nM	110.0	CHEMBL2447	Homo sapiens	IC50	nM	110.0
	3234231	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	COc1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1082101	=	IC50	nM	64.0	CHEMBL2447	Homo sapiens	IC50	nM	64.0
	3234232	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	N#Cc1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079397	=	IC50	nM	49.0	CHEMBL2447	Homo sapiens	IC50	nM	49.0
	3234233	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	CS(=O)(=O)c1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079398	=	IC50	nM	63.0	CHEMBL2447	Homo sapiens	IC50	nM	63.0
	3234234	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	NC(=O)c1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079399	=	IC50	nM	89.0	CHEMBL2447	Homo sapiens	IC50	nM	89.0
	3234235	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccc(C(=O)O)cc4)c3)C2)cc1F		CHEMBL1079758	=	IC50	nM	15300.0	CHEMBL2447	Homo sapiens	IC50	nM	15300.0
	3234236	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccc(Cl)cc4)c3)C2)cc1F		CHEMBL1079759	=	IC50	nM	51.0	CHEMBL2447	Homo sapiens	IC50	nM	51.0
	3234237	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4cccc(Cl)c4)c3)C2)cc1F		CHEMBL1079760	=	IC50	nM	79.0	CHEMBL2447	Homo sapiens	IC50	nM	79.0
	3234238	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccccc4Cl)c3)C2)cc1F		CHEMBL1079415	=	IC50	nM	45.0	CHEMBL2447	Homo sapiens	IC50	nM	45.0
	3234239	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccc(Cl)cc4Cl)c3)C2)cc1F		CHEMBL1079771	=	IC50	nM	21.0	CHEMBL2447	Homo sapiens	IC50	nM	21.0
	3234240	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Cc1cc(Cl)ccc1-c1cccc(S(=O)(=O)N[C@H]2CC[C@H](n3cc(F)c(N)nc3=O)C2)c1		CHEMBL1079432	=	IC50	nM	21.0	CHEMBL2447	Homo sapiens	IC50	nM	21.0
	3234241	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cccc(-c4ccccc4)c3)C2)cc1F		CHEMBL1079433	=	IC50	nM	260.0	CHEMBL2447	Homo sapiens	IC50	nM	260.0
	3234242	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	COc1ccc(-c2cccc(C(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079600	=	IC50	nM	30.0	CHEMBL2447	Homo sapiens	IC50	nM	30.0
	3234243	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cccc(-c4ccc(Cl)cc4)c3)C2)cc1F		CHEMBL1079783	=	IC50	nM	42.0	CHEMBL2447	Homo sapiens	IC50	nM	42.0
	3234244	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cccc(-c4cccc(Cl)c4)c3)C2)cc1F		CHEMBL1076274	=	IC50	nM	23.0	CHEMBL2447	Homo sapiens	IC50	nM	23.0
	3234245	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Cc1cc(Cl)ccc1-c1cccc(C(=O)N[C@H]2CC[C@H](n3cc(F)c(N)nc3=O)C2)c1		CHEMBL1079784	=	IC50	nM	21.0	CHEMBL2447	Homo sapiens	IC50	nM	21.0
	3234246	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	O=C(CN1CCN(c2cc(-c3cc4ccccc4s3)ncn2)CC1)N1CCCC1		CHEMBL1081559	=	IC50	nM	510.0	CHEMBL2447	Homo sapiens	IC50	nM	510.0
	3234247	CHEMBL1101518	Inhibition of human deoxycytidine kinase by lysate filter binding assay	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cc(-c4cc5ccccc5s4)ccn3)C2)cc1F		CHEMBL1080444	=	IC50	nM	1.7	CHEMBL2447	Homo sapiens	IC50	nM	1.7
	3234248	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)C2)cc1F		CHEMBL1079347	=	EC50	nM	16000.0	CHEMBL2447	Homo sapiens	EC50	nM	16000.0
	3234249	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)C2)cc1F		CHEMBL1079348	=	EC50	nM	17000.0	CHEMBL2447	Homo sapiens	EC50	nM	17000.0
	3234250	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Br)cc3)C2)cc1F		CHEMBL1079349	=	EC50	nM	11000.0	CHEMBL2447	Homo sapiens	EC50	nM	11000.0
	3234251	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3ccc(-c4ccccc4)cc3)C2)cc1F		CHEMBL1081909	=	EC50	nM	5500.0	CHEMBL2447	Homo sapiens	EC50	nM	5500.0
	3234252	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Br)c3)C2)cc1F		CHEMBL1081005	=	EC50	nM	2800.0	CHEMBL2447	Homo sapiens	EC50	nM	2800.0
	3234253	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccccc4)c3)C2)cc1F		CHEMBL1081006	=	EC50	nM	600.0	CHEMBL2447	Homo sapiens	EC50	nM	600.0
	3234254	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Cc1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1081189	=	EC50	nM	500.0	CHEMBL2447	Homo sapiens	EC50	nM	500.0
	3234255	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	COc1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1082101	=	EC50	nM	300.0	CHEMBL2447	Homo sapiens	EC50	nM	300.0
	3234256	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	N#Cc1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079397	=	EC50	nM	390.0	CHEMBL2447	Homo sapiens	EC50	nM	390.0
	3234257	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	CS(=O)(=O)c1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079398	=	EC50	nM	1800.0	CHEMBL2447	Homo sapiens	EC50	nM	1800.0
	3234258	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	NC(=O)c1ccc(-c2cccc(S(=O)(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079399	=	EC50	nM	5900.0	CHEMBL2447	Homo sapiens	EC50	nM	5900.0
	3234259	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccc(Cl)cc4)c3)C2)cc1F		CHEMBL1079759	=	EC50	nM	240.0	CHEMBL2447	Homo sapiens	EC50	nM	240.0
	3234260	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4cccc(Cl)c4)c3)C2)cc1F		CHEMBL1079760	=	EC50	nM	360.0	CHEMBL2447	Homo sapiens	EC50	nM	360.0
	3234261	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccccc4Cl)c3)C2)cc1F		CHEMBL1079415	=	EC50	nM	430.0	CHEMBL2447	Homo sapiens	EC50	nM	430.0
	3234262	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccc(Cl)cc4Cl)c3)C2)cc1F		CHEMBL1079771	=	EC50	nM	530.0	CHEMBL2447	Homo sapiens	EC50	nM	530.0
	3234263	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Cc1cc(Cl)ccc1-c1cccc(S(=O)(=O)N[C@H]2CC[C@H](n3cc(F)c(N)nc3=O)C2)c1		CHEMBL1079432	=	EC50	nM	290.0	CHEMBL2447	Homo sapiens	EC50	nM	290.0
	3234264	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cccc(-c4ccccc4)c3)C2)cc1F		CHEMBL1079433	=	EC50	nM	910.0	CHEMBL2447	Homo sapiens	EC50	nM	910.0
	3234265	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	COc1ccc(-c2cccc(C(=O)N[C@H]3CC[C@H](n4cc(F)c(N)nc4=O)C3)c2)cc1		CHEMBL1079600	=	EC50	nM	100.0	CHEMBL2447	Homo sapiens	EC50	nM	100.0
	3234266	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cccc(-c4ccc(Cl)cc4)c3)C2)cc1F		CHEMBL1079783	=	EC50	nM	270.0	CHEMBL2447	Homo sapiens	EC50	nM	270.0
	3234267	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cccc(-c4cccc(Cl)c4)c3)C2)cc1F		CHEMBL1076274	=	EC50	nM	180.0	CHEMBL2447	Homo sapiens	EC50	nM	180.0
	3234268	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Cc1cc(Cl)ccc1-c1cccc(C(=O)N[C@H]2CC[C@H](n3cc(F)c(N)nc3=O)C2)c1		CHEMBL1079784	=	EC50	nM	170.0	CHEMBL2447	Homo sapiens	EC50	nM	170.0
	3234269	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cc(-c4cc5ccccc5s4)ccn3)C2)cc1F		CHEMBL1080444	=	EC50	nM	17.0	CHEMBL2447	Homo sapiens	EC50	nM	17.0
	3234323	CHEMBL1101693	Inhibition of deoxycytidine kinase in anti CD3 and anti CD28 -stimulated human T cells assessed as reduction in [3H]deoxycitidine incorporation	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cc(-c4cc5ccccc5s4)ccn3)C2)cc1F		CHEMBL1080444	=	EC50	nM	17.0	CHEMBL2447	Homo sapiens	EC50	nM	17.0
Not Active	3234324	CHEMBL1101694	Inhibition of deoxycytidine kinase in anti CD3 and anti CD28 -stimulated human T cells assessed as reduction in deoxythymidine incorporation	B	Nc1nc(=O)n([C@H]2CC[C@H](NC(=O)c3cc(-c4cc5ccccc5s4)ccn3)C2)cc1F		CHEMBL1080444		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Determined	3234328	CHEMBL1101519	Inhibition of deoxycytidine kinase-mediated arabinoside C-induced cytotoxicity	B	Nc1nc(=O)n([C@H]2CC[C@H](NS(=O)(=O)c3cccc(-c4ccc(C(=O)O)cc4)c3)C2)cc1F		CHEMBL1079758		EC50			CHEMBL2447	Homo sapiens	EC50		
	3377673	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3[C@H]2F)c(=O)n1		CHEMBL1210987	=	Kcat	/s	0.0214	CHEMBL2447	Homo sapiens	Kcat	/s	0.0214
	3377674	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3[C@@H]2F)c(=O)n1		CHEMBL1210988	=	Kcat	/s	0.1221	CHEMBL2447	Homo sapiens	Kcat	/s	0.1221
	3377675	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3C2(F)F)c(=O)n1		CHEMBL1210989	=	Kcat	/s	0.0599	CHEMBL2447	Homo sapiens	Kcat	/s	0.0599
	3377676	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL223482	=	Kcat	/s	0.016	CHEMBL2447	Homo sapiens	Kcat	/s	0.016
	3377677	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3[C@H]2F)c(=O)n1		CHEMBL1210987	=	Km	nM	60950.0	CHEMBL2447	Homo sapiens	Km	uM	60.95
	3377678	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3[C@@H]2F)c(=O)n1		CHEMBL1210988	=	Km	nM	81100.0	CHEMBL2447	Homo sapiens	Km	uM	81.1
	3377679	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3C2(F)F)c(=O)n1		CHEMBL1210989	=	Km	nM	27600.0	CHEMBL2447	Homo sapiens	Km	uM	27.6
	3377680	CHEMBL1212355	Activity at human recombinant deoxycytidine kinase expressed in HepG2 cells	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL223482	=	Km	nM	81200.0	CHEMBL2447	Homo sapiens	Km	uM	81.2
	3377681	CHEMBL1212357	Ratio of Kcat/Km for human recombinant deoxycytidine kinase	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3[C@H]2F)c(=O)n1		CHEMBL1210987	=	Kcat/Km	10'-4/uM/s	3.5	CHEMBL2447	Homo sapiens	Kcat/Km	10'-4/uM/s	3.5
	3377682	CHEMBL1212357	Ratio of Kcat/Km for human recombinant deoxycytidine kinase	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3[C@@H]2F)c(=O)n1		CHEMBL1210988	=	Kcat/Km	10'-3/microM/s	1.5	CHEMBL2447	Homo sapiens	Kcat/Km	10'-3/microM/s	1.5
	3377683	CHEMBL1212357	Ratio of Kcat/Km for human recombinant deoxycytidine kinase	B	Nc1ccn([C@@H]2O[C@@]3(CO)CO[C@H]3C2(F)F)c(=O)n1		CHEMBL1210989	=	Kcat/Km	10'-3/microM/s	2.2	CHEMBL2447	Homo sapiens	Kcat/Km	10'-3/microM/s	2.2
	3377684	CHEMBL1212357	Ratio of Kcat/Km for human recombinant deoxycytidine kinase	B	C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O		CHEMBL223482	=	Kcat/Km	10'-4/uM/s	1.9	CHEMBL2447	Homo sapiens	Kcat/Km	10'-4/uM/s	1.9
	13449309	CHEMBL2428640	Inhibition of dCK (unknown origin) by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426574	=	Ki	nM	0.5	CHEMBL2447	Homo sapiens	Ki(app)	nM	0.5
	13449310	CHEMBL2428640	Inhibition of dCK (unknown origin) by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426573	=	Ki	nM	0.8	CHEMBL2447	Homo sapiens	Ki(app)	nM	0.8
	13449311	CHEMBL2428640	Inhibition of dCK (unknown origin) by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCCF)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426558	=	Ki	nM	1.5	CHEMBL2447	Homo sapiens	Ki(app)	nM	1.5
	13449312	CHEMBL2428640	Inhibition of dCK (unknown origin) by steady-state kinetic assay	B	COc1ccc(-c2nc(CSc3nc(N)cc(N)n3)c(C)s2)cc1OCCF		CHEMBL2426588	=	Ki	nM	9.5	CHEMBL2447	Homo sapiens	Ki(app)	nM	9.5
	13449313	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426574	=	IC50	nM	4.89	CHEMBL2447	Homo sapiens	IC50	nM	4.89
	13449314	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426573	=	IC50	nM	1.44	CHEMBL2447	Homo sapiens	IC50	nM	1.44
	13449315	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(OCC(C)O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426572	=	IC50	nM	2.85	CHEMBL2447	Homo sapiens	IC50	nM	2.85
	13449316	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(OCCO)c2)nc1CSc1nccc(N)n1		CHEMBL2426571	=	IC50	nM	2.9	CHEMBL2447	Homo sapiens	IC50	nM	2.9
	13449317	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426570	=	IC50	nM	1.15	CHEMBL2447	Homo sapiens	IC50	nM	1.15
	13449318	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(OCCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426569	=	IC50	nM	1.55	CHEMBL2447	Homo sapiens	IC50	nM	1.55
	13449319	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426568	=	IC50	nM	18.62	CHEMBL2447	Homo sapiens	IC50	nM	18.62
	13449320	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OCCO)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426567	=	IC50	nM	2.59	CHEMBL2447	Homo sapiens	IC50	nM	2.59
	13449321	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2cc(F)cc(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426566	=	IC50	nM	8.01	CHEMBL2447	Homo sapiens	IC50	nM	8.01
	13449322	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2cccc(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426565	=	IC50	nM	11.58	CHEMBL2447	Homo sapiens	IC50	nM	11.58
	13449323	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2cc(F)cc(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426564	=	IC50	nM	2.83	CHEMBL2447	Homo sapiens	IC50	nM	2.83
	13449324	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(F)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426563	=	IC50	nM	1.07	CHEMBL2447	Homo sapiens	IC50	nM	1.07
	13449325	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2cccc(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426562	=	IC50	nM	2.45	CHEMBL2447	Homo sapiens	IC50	nM	2.45
	13449326	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2cccc(F)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426561	=	IC50	nM	31.0	CHEMBL2447	Homo sapiens	IC50	uM	0.031
	13449327	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(F)cc2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426560	=	IC50	nM	37.0	CHEMBL2447	Homo sapiens	IC50	uM	0.037
	13449328	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2cc(F)cc(F)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426559	=	IC50	nM	173.0	CHEMBL2447	Homo sapiens	IC50	uM	0.173
	13449329	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCCc1sc(-c2ccc(OC)c(OCCF)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426558	=	IC50	nM	3.0	CHEMBL2447	Homo sapiens	IC50	uM	0.003
	13449330	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCc1sc(-c2cccc(F)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426557	=	IC50	nM	11.0	CHEMBL2447	Homo sapiens	IC50	uM	0.011
	13449331	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCc1sc(-c2ccc(F)cc2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426460	=	IC50	nM	83.0	CHEMBL2447	Homo sapiens	IC50	uM	0.083
	13449332	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCc1sc(-c2cc(F)cc(F)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426459	=	IC50	nM	162.0	CHEMBL2447	Homo sapiens	IC50	uM	0.162
	13449333	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCc1sc(-c2ccc(OC)c(OCCF)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426598	=	IC50	nM	7.0	CHEMBL2447	Homo sapiens	IC50	uM	0.007
	13449334	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1ccc(OCCF)cc1-c1nc(CSc2nc(N)nc(N)n2)cs1		CHEMBL2426597	=	IC50	nM	849.0	CHEMBL2447	Homo sapiens	IC50	uM	0.849
	13449335	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1ccc(-c2nc(CSc3nc(N)nc(N)n3)cs2)cc1OCCCF		CHEMBL2426596	=	IC50	nM	297.0	CHEMBL2447	Homo sapiens	IC50	uM	0.297
	13449336	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	Cc1ccc(-c2nc(CSc3nc(N)nc(N)n3)cs2)cc1OCCF		CHEMBL2426595	=	IC50	nM	1922.0	CHEMBL2447	Homo sapiens	IC50	uM	1.922
	13449337	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCOc1ccc(-c2nc(CSc3nc(N)nc(N)n3)cs2)cc1OCCF		CHEMBL2426594	=	IC50	nM	512.0	CHEMBL2447	Homo sapiens	IC50	uM	0.512
	13449338	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1ccc(-c2nc(CSc3nc(N)nc(N)n3)cs2)cc1OCCF		CHEMBL2426593	=	IC50	nM	506.0	CHEMBL2447	Homo sapiens	IC50	uM	0.506
	13449339	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1cc(-c2nc(CSc3nc(N)nc(N)n3)cs2)ccc1OCCF		CHEMBL2426592	=	IC50	nM	534.0	CHEMBL2447	Homo sapiens	IC50	uM	0.534
	13449340	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	Cc1sc(-c2cccc(F)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426591	=	IC50	nM	92.0	CHEMBL2447	Homo sapiens	IC50	uM	0.092
	13449341	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	Cc1sc(-c2ccc(F)cc2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426590	=	IC50	nM	230.0	CHEMBL2447	Homo sapiens	IC50	uM	0.23
	13449342	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	Cc1sc(-c2cc(F)cc(F)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426589	=	IC50	nM	150.0	CHEMBL2447	Homo sapiens	IC50	uM	0.15
	13452041	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1ccc(-c2nc(CSc3nc(N)cc(N)n3)c(C)s2)cc1OCCF		CHEMBL2426588	=	IC50	nM	18.0	CHEMBL2447	Homo sapiens	IC50	uM	0.018
	13452042	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1cc(OCCF)ccc1-c1nc(CSc2nc(N)cc(N)n2)cs1		CHEMBL2426587	=	IC50	nM	2367.0	CHEMBL2447	Homo sapiens	IC50	uM	2.367
	13452043	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1ccc(OCCF)cc1-c1nc(CSc2nc(N)cc(N)n2)cs1		CHEMBL2426586	=	IC50	nM	1041.0	CHEMBL2447	Homo sapiens	IC50	uM	1.041
	13452044	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1ccc(-c2nc(CSc3nc(N)cc(N)n3)cs2)cc1OCCCF		CHEMBL2426585	=	IC50	nM	197.0	CHEMBL2447	Homo sapiens	IC50	uM	0.197
	13452045	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	Cc1ccc(-c2nc(CSc3nc(N)cc(N)n3)cs2)cc1OCCF		CHEMBL2426584	=	IC50	nM	1960.0	CHEMBL2447	Homo sapiens	IC50	uM	1.96
	13452046	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	CCOc1ccc(-c2nc(CSc3nc(N)cc(N)n3)cs2)cc1OCCF		CHEMBL2426583	=	IC50	nM	251.0	CHEMBL2447	Homo sapiens	IC50	uM	0.251
	13452047	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1ccc(-c2nc(CSc3nc(N)cc(N)n3)cs2)cc1OCCF		CHEMBL2426582	=	IC50	nM	230.0	CHEMBL2447	Homo sapiens	IC50	uM	0.23
	13452048	CHEMBL2429676	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of tritiated deoxycytidine [3H]-dC uptake	B	COc1cc(-c2nc(CSc3nc(N)cc(N)n3)cs2)ccc1OCCF		CHEMBL2426581	=	IC50	nM	421.0	CHEMBL2447	Homo sapiens	IC50	uM	0.421
	13894839	CHEMBL3111362	Activity at recombinant dCK (unknown origin) at 100 uM by HPLC analysis	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888	=	Activity	%	15.0	CHEMBL2447	Homo sapiens	Activity	%	15.0
Not Active	13894847	CHEMBL3111362	Activity at recombinant dCK (unknown origin) at 100 uM by HPLC analysis	B	O=C(CCCCCCCCCCBr)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL3109100		Activity			CHEMBL2447	Homo sapiens	Activity		
Not Active	13894848	CHEMBL3111362	Activity at recombinant dCK (unknown origin) at 100 uM by HPLC analysis	B	CC(C)(C)OC(=O)OC[C@H]1O[C@@H](n2ccc(NC(=O)CCCCCCCCCCBr)nc2=O)C(F)(F)[C@@H]1OC(=O)OC(C)(C)C		CHEMBL3109099		Activity			CHEMBL2447	Homo sapiens	Activity		
	13894849	CHEMBL3111362	Activity at recombinant dCK (unknown origin) at 100 uM by HPLC analysis	B	O=C(CCCCCCCCCCF)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL3109105	<	Activity	%	1.0	CHEMBL2447	Homo sapiens	Activity	%	1.0
	13894850	CHEMBL3111362	Activity at recombinant dCK (unknown origin) at 100 uM by HPLC analysis	B	C=CCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL3108784	<	Activity	%	1.0	CHEMBL2447	Homo sapiens	Activity	%	1.0
	15078745	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	COc1ccc(-c2nc([C@@H](C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCNS(C)(=O)=O		CHEMBL3358097	=	IC50	nM	3.7	CHEMBL2447	Homo sapiens	IC50	nM	3.7
	15078746	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	COc1ccc(-c2nc([C@@H](C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCNS(C)(=O)=O		CHEMBL3358097	=	Ki	nM	9.2	CHEMBL2447	Homo sapiens	Ki(app)	nM	9.2
	15078747	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	COc1ccc(-c2nc([C@@H](C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCNS(C)(=O)=O		CHEMBL3358097	=	IC50	nM	27.8	CHEMBL2447	Homo sapiens	IC50	nM	27.8
	15078748	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	COc1ccc(-c2nc([C@H](C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCNS(C)(=O)=O		CHEMBL3358090	=	IC50	nM	94.0	CHEMBL2447	Homo sapiens	IC50	nM	94.0
	15078749	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	COc1ccc(-c2nc([C@H](C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCNS(C)(=O)=O		CHEMBL3358090	=	Ki	nM	585.0	CHEMBL2447	Homo sapiens	Ki(app)	nM	585.0
	15078750	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	COc1ccc(-c2nc([C@H](C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCNS(C)(=O)=O		CHEMBL3358090	=	IC50	nM	605.0	CHEMBL2447	Homo sapiens	IC50	nM	605.0
	15078751	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCOc1cc(-c2nc([C@@H](C)Sc3nc(N)cc(N)n3)c(C)s2)ccc1OCCOCCOCCOC		CHEMBL3358096	=	IC50	nM	1.25	CHEMBL2447	Homo sapiens	IC50	nM	1.25
	15078752	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCOc1cc(-c2nc([C@@H](C)Sc3nc(N)cc(N)n3)c(C)s2)ccc1OCCOCCOCCOC		CHEMBL3358096	=	Ki	nM	14.0	CHEMBL2447	Homo sapiens	Ki(app)	nM	14.0
	15078753	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCOc1cc(-c2nc([C@@H](C)Sc3nc(N)cc(N)n3)c(C)s2)ccc1OCCOCCOCCOC		CHEMBL3358096	=	IC50	nM	31.7	CHEMBL2447	Homo sapiens	IC50	nM	31.7
	15078754	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCOc1cc(-c2nc([C@H](C)Sc3nc(N)cc(N)n3)c(C)s2)ccc1OCCOCCOCCOC		CHEMBL3358095	=	IC50	nM	429.5	CHEMBL2447	Homo sapiens	IC50	nM	429.5
	15078755	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCOc1cc(-c2nc([C@H](C)Sc3nc(N)cc(N)n3)c(C)s2)ccc1OCCOCCOCCOC		CHEMBL3358095	=	Ki	nM	5607.0	CHEMBL2447	Homo sapiens	Ki(app)	nM	5607.0
	15078756	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCOc1cc(-c2nc([C@H](C)Sc3nc(N)cc(N)n3)c(C)s2)ccc1OCCOCCOCCOC		CHEMBL3358095	=	IC50	nM	5632.0	CHEMBL2447	Homo sapiens	IC50	nM	5632.0
	15078759	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	COc1ccc(-c2nc(C(C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCF		CHEMBL3358094	=	IC50	nM	7.0	CHEMBL2447	Homo sapiens	IC50	nM	7.0
	15078760	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	COc1ccc(-c2nc(C(C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCF		CHEMBL3358094	=	Ki	nM	6.8	CHEMBL2447	Homo sapiens	Ki(app)	nM	6.8
	15078761	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	COc1ccc(-c2nc(C(C)Sc3nc(N)cc(N)n3)c(C)s2)cc1OCCF		CHEMBL3358094	=	IC50	nM	24.7	CHEMBL2447	Homo sapiens	IC50	nM	24.7
	15078764	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OC)c(OCCF)c2)nc1C(C)Sc1nc(N)cc(N)n1		CHEMBL3358093	=	IC50	nM	10.0	CHEMBL2447	Homo sapiens	IC50	nM	10.0
	15078765	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCCF)c2)nc1C(C)Sc1nc(N)cc(N)n1		CHEMBL3358093	=	Ki	nM	16.6	CHEMBL2447	Homo sapiens	Ki(app)	nM	16.6
	15078766	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OC)c(OCCF)c2)nc1C(C)Sc1nc(N)cc(N)n1		CHEMBL3358093	=	IC50	nM	37.2	CHEMBL2447	Homo sapiens	IC50	nM	37.2
	15078767	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OCCO)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426567	=	IC50	nM	0.9	CHEMBL2447	Homo sapiens	IC50	nM	0.9
	15078768	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OCCO)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426567	=	Ki	nM	2.0	CHEMBL2447	Homo sapiens	Ki(app)	nM	2.0
	15078769	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OCCO)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426567	=	IC50	nM	17.9	CHEMBL2447	Homo sapiens	IC50	nM	17.9
	15078770	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2cccc(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426565	=	IC50	nM	11.6	CHEMBL2447	Homo sapiens	IC50	nM	11.6
	15078771	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2cccc(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426565	=	Ki	nM	1.9	CHEMBL2447	Homo sapiens	Ki(app)	nM	1.9
	15078772	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2cccc(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426565	=	IC50	nM	16.8	CHEMBL2447	Homo sapiens	IC50	nM	16.8
	15078773	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OC)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426570	=	IC50	nM	1.15	CHEMBL2447	Homo sapiens	IC50	nM	1.15
	15078774	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426570	=	Ki	nM	0.5	CHEMBL2447	Homo sapiens	Ki(app)	nM	0.5
	15078775	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OC)c(OCCO)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426570	=	IC50	nM	14.6	CHEMBL2447	Homo sapiens	IC50	nM	14.6
	15078776	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OC)c(O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426568	=	IC50	nM	18.6	CHEMBL2447	Homo sapiens	IC50	nM	18.6
	15078777	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426568	=	Ki	nM	8.9	CHEMBL2447	Homo sapiens	Ki(app)	nM	8.9
	15078778	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OC)c(O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426568	=	IC50	nM	26.1	CHEMBL2447	Homo sapiens	IC50	nM	26.1
	15078779	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1cc(N)nc(N)n1		CHEMBL3358092	=	IC50	nM	395.0	CHEMBL2447	Homo sapiens	IC50	nM	395.0
	15078780	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1cc(N)nc(N)n1		CHEMBL3358092	=	Ki	nM	735.0	CHEMBL2447	Homo sapiens	Ki(app)	nM	735.0
	15078781	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1cc(N)nc(N)n1		CHEMBL3358092	=	IC50	nM	754.0	CHEMBL2447	Homo sapiens	IC50	nM	754.0
	15078782	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nccc(N)n1		CHEMBL3358091	=	IC50	nM	21.8	CHEMBL2447	Homo sapiens	IC50	nM	21.8
	15078783	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nccc(N)n1		CHEMBL3358091	=	Ki	nM	1.8	CHEMBL2447	Homo sapiens	Ki(app)	nM	1.8
	15078784	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nccc(N)n1		CHEMBL3358091	=	IC50	nM	11.2	CHEMBL2447	Homo sapiens	IC50	nM	11.2
	15078787	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OC)c(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426574	=	IC50	nM	4.9	CHEMBL2447	Homo sapiens	IC50	nM	4.9
	15078788	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426574	=	Ki	nM	0.5	CHEMBL2447	Homo sapiens	Ki(app)	nM	0.5
	15078789	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OC)c(OCCNS(C)(=O)=O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426574	=	IC50	nM	14.1	CHEMBL2447	Homo sapiens	IC50	nM	14.1
	15078792	CHEMBL3381706	Inhibition of dCK in human CCRF-CEM cells assessed as inhibition of [3H]-dC uptake by scintillation counting analysis	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426573	=	IC50	nM	1.4	CHEMBL2447	Homo sapiens	IC50	nM	1.4
	15078793	CHEMBL3381705	Apparent inhibition of human dCK by steady-state kinetic assay	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426573	=	Ki	nM	0.8	CHEMBL2447	Homo sapiens	Ki(app)	nM	0.8
	15078794	CHEMBL3381704	Apparent inhibition of human dCK assessed as phosphorylation activity by spectroscopic NADH-dependent enzyme-coupled assay	B	CCCc1sc(-c2ccc(OC)c(OCC(C)(C)O)c2)nc1CSc1nc(N)cc(N)n1		CHEMBL2426573	=	IC50	nM	14.5	CHEMBL2447	Homo sapiens	IC50	nM	14.5
	15469173	CHEMBL3538236	Activity of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells assessed as enzyme-mediated 2',2'-difluorodeoxycytidine formation incubated for 1 min by liquid chromatography-tandem mass spectrometry	A	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888	=	Vmax	nmol/min/mg	1057.0	CHEMBL2447	Homo sapiens	Vmax	nmol/min/mg	1057.0
	15469177	CHEMBL3538244	Activity of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry	A	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803	=	Vmax	nmol/min/mg	706.5	CHEMBL2447	Homo sapiens	Vmax	nmol/min/mg	706.5
	15469192	CHEMBL3541975	Drug metabolism assessed as intrinsic clearance for 2',2'-difluorodeoxycytidine formation incubated for 1 min in presence of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells by liquid chromatography-tandem mass spectrometry	A	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1	Outside typical range	CHEMBL888	=	CL	mL.min-1.g-1	491900.0	CHEMBL2447	Homo sapiens	CL	ml/min/mg	491.9
	15469208	CHEMBL3538244	Activity of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells assessed as cytosine-beta-D-arabinofuranoside-5'-MP formation incubated for 3 mins by liquid chromatography-tandem mass spectrometry	A	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803	=	Km	nM	3040.0	CHEMBL2447	Homo sapiens	Km	uM	3.04
	15469212	CHEMBL3538240	Drug metabolism assessed as intrinsic clearance for human recombinant N-terminal His-tagged wild type DCK-mediated cytosine-beta-D-arabinofuranoside-5'-MP formation expressed in Escherichia coli BL21(DE3) incubated for 3 mins by liquid chromatography-tandem mass spectrometry	A	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1	Outside typical range	CHEMBL803	=	CL	mL.min-1.g-1	231400.0	CHEMBL2447	Homo sapiens	CL	ml/min/mg	231.4
	15469215	CHEMBL3541984	Drug metabolism assessed as intrinsic clearance for dFdU monophosphorylation formation incubated for 10 mins in presence of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells measured per mg of protein by liquid chromatography-tandem mass spectrometry	A	O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)[nH]1		CHEMBL3526970	=	CL	mL.min-1.g-1	27.0	CHEMBL2447	Homo sapiens	CL	ml/min/mg	0.027
	15469217	CHEMBL3538236	Activity of human recombinant N-terminal His-tagged wild type DCK expressed in Escherichia coli BL21(DE3) cells assessed as enzyme-mediated 2',2'-difluorodeoxycytidine formation incubated for 1 min by liquid chromatography-tandem mass spectrometry	A	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888	=	Km	nM	2150.0	CHEMBL2447	Homo sapiens	Km	uM	2.15
	16857675	CHEMBL3879665	Binding affinity to DCK in HEK293T cells at 50 uM incubated for 1 hr by mass spectrometry analysis relative to o-ML349-biotin	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCOCCn1cc(COc2ccc(N3CCN(C(=O)c4cc5c(s4)-c4ccccc4S(=O)(=O)C5)CC3)cc2)nn1		CHEMBL3944678	>	FC		5.0	CHEMBL2447	Homo sapiens	FC		5.0
	16857681	CHEMBL3879671	Binding affinity to DCK in HEK293T cells at 50 uM incubated for 1 hr by mass spectrometry analysis relative to azide-PEG3-biotin	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCOCCn1cc(COc2ccc(N3CCN(C(=O)c4cc5c(s4)-c4ccccc4S(=O)(=O)C5)CC3)cc2)nn1		CHEMBL3944678	>	FC		5.0	CHEMBL2447	Homo sapiens	FC		5.0
Inactive	17895457	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895458	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895459	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895460	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895461	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895462	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895463	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895464	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895465	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895466	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895467	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895468	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895469	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895470	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895471	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895472	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895473	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895474	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895475	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895476	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895477	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895478	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895479	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895480	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895481	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895482	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895483	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895484	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895485	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895486	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895487	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895488	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895489	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895490	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895491	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895492	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895493	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895494	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895495	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895496	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895497	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895498	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895499	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895500	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895501	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895502	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895503	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895504	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895505	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895506	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895507	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895508	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895509	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895510	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895511	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895512	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895513	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895514	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895515	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895516	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895517	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895518	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895519	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895520	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895521	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895522	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895523	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895524	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895525	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895526	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895527	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895528	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895529	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895530	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895531	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895532	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895533	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895534	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895535	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895536	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895537	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895538	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895539	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895540	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895541	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895542	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895543	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895544	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895545	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895546	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895547	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Active	17895548	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	12.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	12.0
Inactive	17895549	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895550	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895551	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895552	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895553	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895554	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895555	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895556	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895557	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895558	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895559	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895560	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895561	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895562	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895563	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895564	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895565	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895566	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895567	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895568	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895569	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895570	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895571	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895572	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895573	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895574	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895575	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895576	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895577	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895578	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895579	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895580	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895581	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895582	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895583	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895584	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895585	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895586	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895587	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895588	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895589	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895590	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895591	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895592	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895593	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895594	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895595	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895596	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895597	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895598	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895599	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895600	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895601	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895602	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895603	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Active	17895604	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	2163.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	2163.0
Inactive	17895605	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895606	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895607	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895608	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895609	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895610	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895611	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895612	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895613	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895614	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895615	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895616	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895617	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895618	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895619	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895620	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895621	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895622	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895623	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895624	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895625	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895626	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895627	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895628	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895629	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895630	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895631	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895632	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895633	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895634	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895635	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895636	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895637	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895638	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895639	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895640	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895641	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895642	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895643	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895644	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895645	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895646	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895647	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895648	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895649	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895650	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895651	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895652	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895653	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895654	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895655	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895656	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895657	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895658	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895659	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895660	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895661	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895662	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895663	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895664	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895665	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895666	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895667	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895668	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895669	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895670	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895671	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895672	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895673	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895674	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895675	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895676	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895677	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895678	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895679	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895680	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895681	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895682	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895683	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895684	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895685	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895686	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895687	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895688	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895689	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895690	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895691	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895692	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895693	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895694	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17895695	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	6175.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	6175.0
Inactive	17895696	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895697	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895698	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17895699	CHEMBL3991683	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2447	Homo sapiens	Kd apparent	nM	30000.0
